Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia

ANALYTE_TYPE - Analyte Type (phv00528036.v2.p1)
BODY_SITE - Body site where sample was collected (phv00528035.v2.p1)
CONSENT - Consent group as determined by DAC (phv00528028.v1.p1)
DISEASE_TYPE - Disease status of the subject (phv00531493.v1.p1)
GEO_ACCESSION - GEO accession ID (GSM#) (phv00528033.v1.p1)
IS_TUMOR - Tumor status (phv00528037.v2.p1)
SAMPLE_ID - Sample ID (phv00528034.v2.p1)
SAMPLE_ID - Sample ID (phv00528031.v2.p1)
SAMPLE_ID - Sample ID (phv00528032.v1.p1)
SAMPLE_TIMEPOINTS - Timepoint of sample collection (phv00528038.v2.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00528039.v2.p1)
STUDY_ARM - Trial study arm (phv00531494.v1.p1)
SUBJECT_ID - Subject ID (phv00531492.v1.p1)
SUBJECT_ID - Subject ID (phv00528027.v1.p1)
SUBJECT_ID - Subject ID (phv00528030.v2.p1)
TRANSPLANT_STATUS - Transplant status of subject (phv00531495.v1.p1)